Hospital News and Research

RSS

Obesity centre behind major staff expansion

The University of Sydney is embarking on one of its largest ever recruitment drives in the wake of recent federal funding for an international centre of expertise in obesity, diabetes and cardiovascular disease.

19 Jan 2009

Report confirms serious health system capacity challenge

The Alternate Level of Care in Canada report released yesterday by the Canadian Institute for Health Information (CIHI) substantiates the Ontario Hospital Association's (OHA) long-standing concerns about the seriousness of alternate level of care (ALC) challenges and lack of capacity across the patient care continuum.

19 Jan 2009

Exercise after menopause lowers breast cancer risk

Several studies had previously suggested that regular physical exercise reduces the breast cancer risk of women.

19 Jan 2009

Taser study finds serious injuries rare after Taser use

An emergency medicine researcher at Wake Forest University Baptist Medical Center has just published the first large, independent study of injuries from conducted electrical weapon (CEW) or Taser use, finding that serious injuries occurred in fewer than 1 percent of 1,201 Taser uses by law enforcement officers.

19 Jan 2009

Lack of grey matter linked to schizophrenia and bipolar disorder

A research study led by scientists from the Gregorio Marañón University Hospital in Madrid and the Network of Centres for Biomedical Research in Mental Health Networks (CIBERSAM) shows that adolescents experiencing a first outbreak of psychosis have lower levels of grey matter in their brains than healthy teenagers. Strangely, this change was seen in patients suffering from various psychoses, including bipolar illness and schizophrenia.

19 Jan 2009

Higher mortality among unscreened children

Swedish researchers have previously shown that as maternity ward stays become shorter, more and more newborns leave the hospital with undetected life-threatening congenital heart disease.

19 Jan 2009

Cancer survivor needs examined beyond specialized care

According to the National Cancer Policy Board, it is estimated that by the year 2050 there will be more cancer survivors in the United States than those newly diagnosed with the disease.

19 Jan 2009

Fish oil helps premmie baby girls avoid learning disabilities

According to a study by Australian researchers premature babies who were given high doses of omega-3 fatty acid were less likely to have developmental delays - but this only applied to baby girls.

18 Jan 2009

Breakthrough in treating premature babies at risk of developmental disorders

A six-year study led by Dr Maria Makrides from the Women's and Children's Health Research Institute and Professor Bob Gibson from the University of Adelaide has demonstrated that high doses of fatty acids administered to pre-term infants via their mother's breast milk or infant formula can help their mental development.

15 Jan 2009

The retina reveals deadly secrets of malaria

Looking at the retina in the eyes of patients with cerebral malaria has provided scientists with a vital insight into why malaria infection in the brain is so deadly.

15 Jan 2009

Telephone support after traffic accidents reduces problems and improves quality of life

People who were injured in road accidents had fewer problems and a much higher quality of life if they received a simple follow-up call from a nurse three weeks after being discharged from hospital, according to research in the January issue of the Journal of Clinical Nursing.

15 Jan 2009

Study shows how defective DNA repair triggers 2 neurological diseases

Scientists at St. Jude Children's Research Hospital have teased apart the biological details distinguishing two related neurological diseases-ataxia telangiectasia-like disease (ATLD) and Nijmegen breakage syndrome (NBS).

15 Jan 2009

Probiotics prevent IgE-associated allergy until age 5 in cesarean-delivered children but not in total cohort

According to a recent study from the University and the University Central Hospital of Helsinki, Finland, no allergy-preventive effect is extended to age 5 years by perinatal supplementation with probiotics in babies at risk for developing allergies; protection is conferred only to Cesarean section babies.

15 Jan 2009

New diagnostic tool to measure blood flow could prevent needless stents

Doctors may be implanting too many artery-opening stents and could improve patient outcomes - and ultimately save lives - if they did more in-depth measurements of blood flow in the vessels to the heart.

15 Jan 2009

New model system may better explain regulation of body weight

A new mathematical model of the physiological regulation of body weight suggests a potential mechanism underlying the difficulty of losing weight, one that includes aspects of two competing hypotheses of weight regulation.

15 Jan 2009

New drug shows promise for phenylketonuria

PKU is described by scientists as an autosomal recessive genetic disease that is characterized by a deficiency in an enzyme called phenylalanine hydroxylase (PAH).

15 Jan 2009

Most support Alzheimer's research based on family consent

By the time they have been diagnosed with Alzheimer's disease, many patients' decision-making ability is so impaired that they cannot give informed consent to participate in research studies.

15 Jan 2009

Invatec launches drug-eluting balloon to treat atherosclerosis below the knee

Invatec, a comprehensive innovator of interventional products, today announced the European launch of a new peripheral balloon, the IN.PACT Amphirion paclitaxel-eluting PTA balloon catheter.

15 Jan 2009

Simple surgical checklist during major operations lowers deaths and complications

A collection of hospitals in eight cities around the globe has successfully demonstrated that the use of a simple surgical checklist during major operations can lower the incidence of deaths and complications by more than one third.

15 Jan 2009

Algeta completes phase II trial with Alpharadin for treating bone metastases in advanced prostate cancer

Algeta ASA has announced that with the results of the BC1-04 study reported today it has completed its comprehensive phase II clinical program evaluating Alpharadin (radium-223) as a new treatment for bone metastases in patients with hormone-refractory prostate cancer (HRPC).

15 Jan 2009